CIK 0001811063 · Non-accelerated filer<br>Smaller reporting company
Nuvation Bio Inc.
Sign in to watch- Ticker
- NUVB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850862255
- Phone
- 332-208-6102
- Business address
- 1 PENNSYLVANIA PLAZA, SUITE 3805, NEW YORK, NY, 10019
- Former names
- Panacea Acquisition Corp
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- POS AM Other Post-effective Amendment for Registration Statement
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Results of operations
- 10-K Report Annual Report
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 424B3 Offering Prospectus
- 8-K Event Results of operations
- 424B3 Offering Prospectus
- 8-K Event Regulation FD disclosure
- 4 Open-market sale 10% owner sold 500,000 shares at $10.07 ($5,035,000)
- 4 Open-market sale 10% owner sold 1,400,000 shares at $9.80 ($13,720,000)
- 4 Open-market buy Director bought 393,168 shares at an average $8.89 ($3,494,733)
- 4 Open-market sale 10% owner sold 295,036 shares at an average $9.76 ($2,879,551)
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 14 of 20 · 400 filings